Drugmakers Tap Big Law Attorneys to Fight Medicare Price Program

Major drugmakers have assembled an army of top attorneys from the nation’s most prestigious firms to take down Medicare’s drug price negotiation program, hoping to take advantage of experience gained in health litigation, arguments before the Supreme Court, and policymaking inside the federal government.

The attack on the drug negotiation program marks the latest attempt by industry to throw everything it has into cutting down a federal health program. Attorneys have noted the fight against the Affordable Care Act as a similar example of industry unifying against the government as it tries to revamp long-standing practices in health care. In ...